Taken together, these findings suggest that CXCL3 may facilitate the malignant progression of liver cancer by regulating the expression of CXCR2 ligands and coordinating immune cell recruitment within the tumor microenvironment. This evidence concerns the gene CXCR2 and neoplasm.